2Varga J. Systemic sclerosis: an update.Bull NYU Hosp Jt Dis, 2008,66:198-202.
3Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coil Cardiol, 2004,43: (Suppl12), 13S-24S.
4Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum,2005,52: 3792-3800.
5Trad S, Amoura Z, Beigelman C, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum, 2006; 54: 184-191.
6De Azevedo AB, Sampaio-Barros PD, Tortes RM, et al.Prevalence of pulmonary hypertension in systemic sclerosis. Clin Exp Rheumatol ,2005,23:447-454.
7Fisher MR, Mathai SC, Champion HC,et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.Arthritis Rheum, 2006, 54: 3043-3050.
8Denton CP, Bcailes JB, Phillips GD, et al. Comparison of doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Brit J Rheumatol, 1997,36:239-243.
9Meyer O. Prognostic markers for systemic sclerosis. Joint Bone Spine, 2006, 73: 490-494.
10Gonzalez LL,Cardona ME,Celis A,et al.Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus[J].Lupus,2004,13(2):105-112.
